Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NSABP B-31: Adjuvant Trastuzumab in HER2+ Breast Cancer
NCT00004067Phase 3Completed
- Sponsor
- NSABP Foundation
- Start
- Feb 2000
- Primary completion
- Mar 2005
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 3 trial of trastuzumab in breast cancer, sponsored by NSABP Foundation. Started Feb 2000; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00004067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004067.